UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000023591
Receipt number R000027167
Scientific Title Feasibility study of neoadjuvant gemcitabine plus nab-paclitaxel for borderline resectable pancreatic cancer
Date of disclosure of the study information 2016/08/10
Last modified on 2019/03/07 16:21:25

No. Disposal Last modified on Item of update
1 Insert 2016/08/10 20:43:26
2 Update 2018/01/12 08:57:29


3 Update 2018/09/20 10:37:27 Recruitment status
4 Update 2019/01/31 18:53:33 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
5 Update 2019/03/07 16:21:25 Recruitment status